Secondary Prevention in Patients with Peripheral Arterial Disease: Are We Letting Our Patients Down?

European Journal of Vascular and Endovascular Surgery

Volumn 33, Issue 2, 2007, Pages 190-191

  Vohra, R S ^a   Gough, M J ^a   Homer Vanniasinkam, S ^a   Mavor, A I D ^a   Howell, S ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RAMIPRIL;

ARTERY DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DATA ANALYSIS; DATA BASE; EDITORIAL; GENERAL PRACTITIONER; HEART PROTECTION; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; NURSE PRACTITIONER; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; RENOVASCULAR DISEASE; RISK FACTOR; SECONDARY PREVENTION; SURGEON;

HUMANS; PERIPHERAL VASCULAR DISEASES; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 33846142468     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.11.007     Document Type: Editorial

References (9)

1. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 6 (1992) 381-386
2. Bhatt D.L., Steg P.G., Ohman E.M., Hirsch A.T., Ikeda Y., Mas J.L., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 2 (2006) 180-189
3. Hertzer N.R., Beven E.G., Young J.R., O'Hara P.J., Ruschhaupt W.F., Graor R.A., et al. Coronary artery disease in peripheral vascular patients. Ann Surg 199 2 (1984) 223-233
4. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. BMJ 320 7236 (2000) 705-708
5. Radack K., and Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. Arch Intern Med 151 9 (1991) 1769-1776
6. Devereaux P.J., Yusuf S., Yang H., Choi P.T., and Guyatt G.H. Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?. Can Med Assoc J 171 3 (2004) 245-247
7. Ostergren J., Sleight P., Dagenais G., Danisa K., Bosch J., Qilong Y., et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 25 1 (2004) 17-24
8. Hobbs S.D., Thomas M.E., and Bradbury A.W. Manipulation of the renin angiotensin system in peripheral arterial disease. Eur J Vasc Endovasc Surg 28 6 (2004) 573-582
9. Youssef F., Gupta P., Mikhailidis D.P., and Hamilton G. Risk modification in patients with peripheral arterial disease: a retrospective survey. Angiology 56 3 (2005) 279-287